Seeking Alpha

IMGN
ImmunoGen, Inc. - NASDAQ

4/16/2014, 6:18 PM ET
Quote & Analysis Breaking News StockTalk
imgn chart
Today 5d 1m 3m 1y 5y 10y
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
FOCUS  |  RELATED  |  TRANSCRIPTS  |  OTHER NEWS & PR
PRO Articles
There is research on this stock available only to PRO subscribers.
Other Articles
IMGN vs. ETF Alternatives
Company Description

Immunogen, Inc. is focused on the antibody-based anticancer therapeutics for the treatment of cancer using cancer biology, monoclonal antibodies and small molecule cytotoxic or cell-killing, agents.

Sector: Healthcare
Industry: Biotechnology
Country: United States